Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Narvitas_Pres_Rev_2_April_2015

416 views

Published on

Narvitas Pres Rev 2 April 2015

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Narvitas_Pres_Rev_2_April_2015

  1. 1. Corporate Presentation March 2015
  2. 2. Narvitas Medical Devices • Develop, patent, manufacture and sell propriety medical devices • 3 Initial Platforms, each leveraging the core technology • Class 1 - Large market segment – High Volume procedures Laparoscopic Epidural Anesthesia Med Surg 8.1 mil procedures worldwide 130 mil birth 60% epidurals In dwelling catheter collection EpiDome Jaws
  3. 3. Management Team Glenn Foley Co-Founder & Director Chief Executive Officer AVE, Medtronic, Precision Vascular Arthur Malvett Co-Founder & Director Chief Operating Officer Life Care Medical, Midland Bank Daragh Sharkey Co-Founder & Director Sales & Business Development Aerogen, Altana, Trojan Med
  4. 4. Clinical Challenge New Modality Improved Standard of Care • Challenge: GYN Laparoscopic Surgery Access – Veress Needle is a blind shot – Labor intensive • 10-12 minutes to full insulflation – Published complication rates = 2-4% • Vital organs in abdominal bed • Revert to open surgery • One week hospitalization • New Modality
  5. 5. Product Development RFQ’s out to the following engineering design firms: • Movement ( Dublin ) LapDome Mini • Advant ( Galway ) LapDome Plus • Knowvention ( US ) EpiDome • Devicix ( US ) “Jaws” • Design LapDome Pedi • Narvitas access to engineering firms • Narvitas access to University of Minnesota Medical Center MDs
  6. 6. Intellectual Property Update Original claims in “temporary pneumoperitoneum” ( Foley 1 ) • Owned by Medical Device International and assigned to Life Care Medical • Life Care defaulted • Default judgment in favor of Medical Device International in Hong Kong • Sealed judgment awarded to Medical Device International • Medical Device International assigned property to Narvitas Second set of claims around “temporary pneumoperitoneum” ( Foley 2 ) • Filed in UK • Search report uneventful • Move to PCT EpiDome claims • UK search report yielded inventive steps • Move to PCT
  7. 7. New Strategic Partners Velocimed St. Jude Veryan BioSensors ( distribution ) Bridgepoint BSC Lutomix Bard MedNova Abbott High Growth Technology Group Narvitas UK branch office
  8. 8. Product Pipeline and Timing Device Class CE FDA JMOH I CQ2 2015 CQ4 2015 CQI 2016 2A Kits inc Veress CQ1 2016 CQ2 2016 CQ4 2016 CQ4 2015 CQ4 2015 CQ1 2016 CQ1 2016 CQ2 2016 CQ2 2016
  9. 9. Distributor Strategy - USA Surgical Principals Inc. Active Medical EA Medical Mediflex CS Surgical Adler Instruments Support Programs from Eisner Medical Ltd • Europe/ME referral centers • White papers • Registry • Published papers • Economic Impact analysis Eisner Medical Ltd– Consultants who are advising on market entry
  10. 10. Financial Forecast
  11. 11. Liquidity and Exit
  12. 12. What we are looking for? €452k Subscribed €550k Open €2.3m Valuation

×